Executive Summary
A cluster of 12 insolvency and restructuring filings on February 4, 2026, reveals a wave of distress across Indian corporates, with 10/12 exhibiting bearish sentiment and critical/high risk levels, centered on ongoing Corporate Insolvency Resolution Processes (CIRP) and NCLT-supervised schemes. Dominant themes include advanced CIRP stages (e.g., Jaiprakash Associates' 26th CoC meeting vs AGS Transact's 6th), creditor/shareholder meetings signaling unresolved defaults, and limited disclosures on default amounts, creditor claims, or financial metrics, amplifying uncertainty. No period-over-period financial trends (YoY/QoQ revenue, margins) or positive operational metrics disclosed across filings, with all lacking quantitative data on debt, assets, or recoveries. Portfolio-level pattern: 7 companies in active CIRP (bearish progression), 3 with unsecured creditor meetings highlighting debt distress; pharma (Aster DM), consumer (Hindware), and infra (Jaiprakash, Refex) sectors most exposed. Market implications: Near-total shareholder wipeout risk in CIRPs, potential liquidation cascades; schemes offer slim restructuring upside but execution uncertainty prevails. No insider trading, capital allocation (dividends/buybacks), or forward guidance changes noted, underscoring opacity amid distress.
Tracking the trend? Catch up on the prior India MCA Insolvency Liquidation Filings digest from February 03, 2026.
Investment Signals(11)
- AGS Transact Technologies (543451)(BEARISH)▲
Ongoing CIRP with 6th CoC meeting outcome disclosed, bearish sentiment, critical risk 10/10, no resolution plan details
- Hindware Home Innovation (542905)(BEARISH)▲
Multiple NCLT Kolkata-directed meetings for equity shareholders and unsecured creditors on composite scheme, bearish sentiment high risk 8-9/10, signals voluntary restructuring amid distress
- Refex Renewables (531260)(BEARISH)▲
Pre-CIRP Section 7 petition listed against step-down subsidiary Sherisha Solar LLP by NCLT Chennai, bearish high risk 8/10, potential material sub impact
- Arshiya Ltd(BEARISH)▲
Creditor list published under IBBI Reg 13(2)(c) confirming active CIRP, bearish critical risk 10/10, no claims details
- BKM Industries (539043)(BEARISH)▲
Record date fixed for NCLT CIRP orders (Nov/Dec 2025), bearish critical risk 10/10, progression to implementation phase
- Jaiprakash Associates (532532)(BEARISH)▲
26th CoC meeting intimated in prolonged CIRP, bearish critical risk 9/10, advanced stage vs peers (e.g., AGS 6th) indicates delays
- Aster DM Healthcare (540975)(BEARISH)▲
NCLT Hyderabad-directed meetings for equity shareholders and unsecured creditors on March 10, 2026, bearish critical risk 10/10, pharma sector exposure
- Hindware Home Innovation↓(BEARISH)▲
Newspaper publications for NCLT court-convened meetings under LODR Reg 30, bearish critical risk 9/10, insolvency proceedings opacity
- AGS Transact Technologies↓(BEARISH)▲
CIRP update via BSE with no proceeding details, bearish critical risk 10/10, continued distress
- Hindware Group Scheme(MILD BULLISH)▲
Composite demerger/merger scheme under Companies Act (not IBC), neutral-to-bearish medium-high risk 6-9/10, relative outperformance vs pure CIRP peers
- Refex Renewables↓(MILD BULLISH)▲
Subsidiary-only CIRP limits parent contagion vs full-company cases like Jaiprakash
Risk Flags(8)
- AGS Transact / CIRP Progression↓[HIGH RISK]▼
6th CoC meeting with no decisions/resolution plans disclosed, critical risk 10/10, liquidation threat if no viable plan
- ▼
Multiple NCLT meetings for unsecured creditors signal debt distress, high risk 8-9/10, no default quantum revealed
- Jaiprakash Associates / Prolonged CIRP↓[CRITICAL RISK]▼
26th CoC meeting indicates multi-year delays vs early-stage peers, critical risk 9/10
- Aster DM Healthcare / NCLT Insolvency↓[CRITICAL RISK]▼
Dual shareholder/unsecured creditor meetings March 10, critical risk 10/10, pharma dilution/wipeout potential
- Arshiya Ltd / Creditor List[HIGH RISK]▼
CIRP creditor publication with no claims details, critical risk 10/10, recovery uncertainty
- BKM Industries / Record Date[HIGH RISK]▼
Fixed for Nov/Dec 2025 NCLT CIRP orders, critical risk 10/10, implementation risks undisclosed
- Refex Renewables / Subsidiary Petition↓[MEDIUM-HIGH RISK]▼
Section 7 IBC listing for Sherisha Solar, high risk 8/10, LODR material sub implications
- Hindware / Scheme Uncertainty↓[HIGH RISK]▼
NCLT scheme lacks timelines/debt details, high risk 9/10, approval failure risk
Opportunities(7)
- Hindware Home Innovation / Restructuring Scheme↓(OPPORTUNITY)◆
Composite scheme approval could simplify group (demerger to HHIL, transfer to Hindware), neutral sentiment vs bearish peers, materiality 6-9/10
- Aster DM Pharma / March 10 Meetings(OPPORTUNITY)◆
NCLT-directed VC/OAVM meetings for shareholders/creditors offer resolution catalyst if viable plan emerges, pharma turnaround potential
- BKM Industries / Record Date Implementation(OPPORTUNITY)◆
Fixed record date for NCLT CIRP orders signals progression to execution, monitor for recovery upside
- Refex Renewables / Sub-Limited Impact↓(OPPORTUNITY)◆
Step-down sub CIRP (Sherisha Solar) may contain contagion, renewables sector relative strength
- Jaiprakash Associates / Advanced CoC↓(OPPORTUNITY)◆
26th meeting experience could accelerate resolution vs early-stage CIRPs like AGS
- Hindware / Equity Shareholder Vote↓(OPPORTUNITY)◆
NCLT Kolkata meeting for scheme approval, potential structure simplification if passed
- Arshiya Ltd / Creditor List Step(OPPORTUNITY)◆
Publication advances CIRP, opportunity for plan shortlisting post-claims verification
Sector Themes(6)
- Prolonged CIRP Across Infra/Construction◆
Jaiprakash (26th CoC), BKM (NCLT orders) show advanced stages vs early (AGS 6th), implying 2+ year timelines, shareholder wipeout risk elevated 9-10/10
- Creditor Meetings Surge in Consumer/Pharma◆
Hindware (4 filings unsecured/equity), Aster (2 filings) highlight unsecured debt distress, bearish sentiment 100%, no recovery metrics disclosed
- NCLT-Supervised Schemes vs Pure IBC◆
Hindware Companies Act schemes (neutral-medium risk) outperform pure CIRP critical risks (8/10 filings), voluntary restructuring edge
- Subsidiary Contagion Limited◆
Refex step-down LLP petition (high risk 8/10) vs parent CIRPs, lower materiality for diversified parents
- Disclosure Opacity Universal◆
12/12 filings lack default amounts/claims/financials, amplifying volatility; critical risk avg 9/10
- Pharma/Tech Distress Clusters◆
Aster DM (pharma), AGS Transact (tech) in active CIRP/meetings, sector bearish sentiment 100%
Watch List(8)
Monitor NCLT Hyderabad equity vote March 10, 2026 10AM IST for resolution plan approval, dilution risk [March 10, 2026]
VC/OAVM meeting March 10, 2026 2PM IST, watch creditor approvals amid pharma insolvency [March 10, 2026]
Track equity/unsecured creditor votes on composite scheme, execution post-approval [TBD post-Feb 04]
Post-6th CoC outcome, watch for 7th meeting or resolution plans in CIRP [Near-term]
Advanced CIRP stage, monitor next meeting intimation for liquidation/plan risks [Near-term]
- BKM Industries / Record Date Effects👁
Post-Feb 04 record date for NCLT orders, track CIRP implementation impacts [Immediate]
NCLT Chennai Section 7 listing, watch admission/RP appointment for sub-resolution [Near-term]
- Arshiya Ltd / Post-Creditor List👁
Monitor CIRP advancements like CoC formation or plans after Reg 13 publication [Near-term]
Filing Analyses(12)
04-02-2026
AGS Transact Technologies Limited (BSE: 543451) has provided an update on its ongoing Corporate Insolvency Resolution Process (CIRP) via BSE filing dated February 04, 2026. No specific details on proceeding stage, default amounts, creditors, claims distribution, resolution plans, or timelines are disclosed. Sector context and financial position remain unspecified, indicating continued insolvency proceedings with limited visibility.
- ·Event Type: Insolvency (CIRP Updates)
- ·Filing Source: BSE
- ·Stock Code: 543451
04-02-2026
AGS Transact Technologies Limited (BSE: 543451) has disclosed the outcome of the 6th meeting of the Committee of Creditors (CoC) under the Corporate Insolvency Resolution Process (CIRP) on February 04, 2026. This confirms the company remains in the ongoing CIRP stage with no specific details on meeting decisions, creditor claims, or resolution plans provided. No quantitative financial metrics, creditor distributions, or timelines were mentioned.
- ·Insolvency proceeding at CIRP stage: 6th CoC meeting outcome disclosed
- ·Event date: February 04, 2026
- ·Source: BSE announcement
- ·Sector: NOT_DISCLOSED
- ·No details on default amount, creditors, claims distribution, resolution plans, or timelines
04-02-2026
Hindware Home Innovation Limited (BSE: 542905) has issued a notice for a meeting of equity shareholders convened as per directions of the Hon'ble National Company Law Tribunal, Kolkata Bench, regarding a Composite Scheme of Arrangement between Hindware Home Innovation Limited (Demerged Company/Remaining Transferor Company), HHIL Limited (Resulting Company), and Hindware Limited (Transferee Company) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013. This is a corporate restructuring via scheme of arrangement, not an IBC insolvency proceeding; no financial metrics, creditor details, default amounts, or timelines are disclosed. No positive or negative performance metrics provided.
- ·Event not an IBC insolvency; scheme of arrangement under Companies Act via NCLT Kolkata Bench
- ·Involves equity shareholders meeting for approval
- ·No details on insolvency stage, trigger, creditors, claims, resolution prospects, or stakeholder impacts disclosed
04-02-2026
Hindware Home Innovation Limited has issued a notice for a meeting of the unsecured creditors of its subsidiary Hindware Limited, convened as per directions from the Hon'ble National Company Law Tribunal, Kolkata Bench. This pertains to a composite scheme of arrangement involving demerger from Hindware Home Innovation Limited (Demerged Company/Remaining Transferor Company), formation of HHIL Limited (Resulting Company), and transfer to Hindware Limited (Transferee Company) under Sections 230 to 232 of the Companies Act, 2013. No financial details, default amounts, creditor information, timelines, or quantitative metrics are disclosed in the filing.
- ·Event involves unsecured creditors of subsidiary Hindware Limited only
- ·Scheme is under Companies Act (not IBC CIRP), indicating voluntary restructuring rather than formal insolvency
04-02-2026
Hindware Home Innovation Limited has issued a notice for the meeting of unsecured creditors, convened as per directions of the Hon'ble National Company Law Tribunal (NCLT), Kolkata Bench, in the matter of a composite scheme of arrangement under Sections 230 to 232 of the Companies Act, 2013. The scheme involves Hindware Home Innovation Limited (Demerged Company/Remaining Transferor Company), HHIL Limited (Resulting Company), and Hindware Limited (Transferee Company), along with their respective shareholders and creditors. No financial metrics, default amounts, timelines, or meeting dates are disclosed.
- ·Scheme directed by NCLT Kolkata Bench specifically convenes meeting of unsecured creditors
- ·Involves demerger, merger elements in composite structure
04-02-2026
Refex Renewables & Infrastructure Ltd (531260) disclosed an update on the initiation of Corporate Insolvency Resolution Process (CIRP) against its step-down wholly-owned subsidiary Sherisha Solar LLP. The Hon'ble NCLT Chennai has listed a Section 7 petition under IBC (financial creditor) along with the Company's petition under Sections 241, 242 of the Companies Act, 2013; copies of orders attached. No quantitative financial details such as default amount, debt, assets, or revenue are disclosed.
- ·Insolvency proceeding stage: Pre-CIRP (Section 7 petition listed, no admission or RP appointment mentioned)
- ·Trigger: Financial creditor petition under IBC Section 7; default amount NOT_DISCLOSED
- ·Company size (subsidiary): Total debt/assets/revenue NOT_DISCLOSED
- ·Claims/creditors: NOT_DISCLOSED
- ·Resolution prospects: NOT_DISCLOSED; timeline typically 180-330 days post-admission but hearing date NOT_DISCLOSED
- ·Stakeholder impact: NOT_DISCLOSED
- ·Precedent value: NOT_DISCLOSED
- ·Source: BSE; Event date: 2026-02-04
04-02-2026
Hindware Home Innovation Limited announced newspaper publications for court-convened meetings as ordered by the Hon'ble NCLT under Regulation 30 (LODR). This disclosure relates to ongoing insolvency proceedings but provides no quantitative financial details, creditor information, timelines, or operational metrics. No positive developments or metrics are mentioned.
- ·Event pertains to insolvency proceedings
- ·Court convened meetings ordered by Hon'ble NCLT
- ·Source: BSE announcement dated February 04, 2026
04-02-2026
Arshiya Ltd has published the list of creditors as required under regulation 13(2)(c) of the IBBI (Insolvency Resolution Process for Corporate Persons) Regulations 2016, as part of its ongoing Corporate Insolvency Resolution Process (CIRP). This disclosure confirms CIRP is in progress but provides no specific details on creditors, claims, default amounts, or financial metrics. No positive operational or financial updates are mentioned alongside the insolvency proceedings.
04-02-2026
BKM Industries Ltd (539043) has fixed a record date for giving effect to NCLT orders dated November 14, 2025, and December 4, 2025, and other relevant orders pronounced under the Corporate Insolvency Resolution Process (CIRP). This corporate action signals progression in insolvency proceedings but provides no details on financial metrics, creditor recoveries, or implementation terms. No quantitative data or sector context disclosed.
- ·Scrip code: 539043
- ·Source: BSE
- ·Event date: February 04, 2026
- ·NCLT Order dates: 2025-11-14 and 2025-12-04
- ·Sector: NOT_DISCLOSED
04-02-2026
Jaiprakash Associates Limited (532532) has filed an intimation regarding the 26th Meeting of the Committee of Creditors (CoC) as part of its ongoing Corporate Insolvency Resolution Process (CIRP). This disclosure from BSE on February 04, 2026, signals an advanced stage in the insolvency proceedings with multiple CoC meetings already conducted. No financial metrics, creditor details, meeting dates, or resolution timelines were disclosed.
- ·Event Type: Insolvency - CIRP stage with 26th CoC meeting intimated
- ·Source: BSE announcement on 2026-02-04
- ·Sector: NOT_DISCLOSED
04-02-2026
Aster DM Healthcare Limited has issued a notice for a meeting of equity shareholders on March 10, 2026, at 10:00 A.M. IST via VC/OAVM, convened as per directions from the Hon'ble NCLT Hyderabad in insolvency proceedings. No financial metrics, creditor details, default amounts, or resolution plan terms are disclosed in the filing. This development signals ongoing NCLT-directed process in the pharma sector, with no quantitative data on company size, debt, or recovery prospects provided.
- ·Event sourced from BSE announcement dated February 04, 2026
- ·Company scrip code: 540975
- ·Sector: pharma
04-02-2026
Aster DM Healthcare Limited (BSE: 540975) has issued a notice for a meeting of its Unsecured Creditors, as directed by the Hon'ble NCLT Hyderabad, to be held on March 10, 2026 at 02:00 P.M. IST through VC/OAVM. This disclosure pertains to ongoing insolvency proceedings in the pharma sector. No financial metrics, default amounts, creditor details, or resolution timelines are disclosed in the filing.
- ·Filing date: February 04, 2026
- ·Source: BSE
- ·Stock code: 540975
- ·Sector: pharma
- ·Court: Hon'ble NCLT Hyderabad
Get daily alerts with 11 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 12 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup — March 25, 2026
India Pre-Market Regulatory Roundup